Pricing Log in Create free account

TherapeuticsMD, Inc. (TXMD) vs Universe Pharmaceuticals INC (UPC)

TherapeuticsMD, Inc. and Universe Pharmaceuticals INC are both Drug Manufacturers Specialty & Generic companies. TherapeuticsMD, Inc. and Universe Pharmaceuticals INC are of similar size ($22.3M and $20.9M). Universe Pharmaceuticals INC has the higher net margin (−6.42% vs −6.64%) and the higher return on invested capital (0.00% vs −13.8%). Across the 15 metrics below, Universe Pharmaceuticals INC leads on 9 and TherapeuticsMD, Inc. on 6.

Valuation

Metric TXMD UPC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 6.73 n/m 2.11
P/B 0.81 n/m 1.78
Price to free cash flow 8.08 n/m 16.14
EV/EBITDA n/m 8.52 12.58
EV/Sales 85.06 (0.24) 2.73
Earnings yield (1.23%) (36.78%) (4.38%)
Free cash flow yield 12.37% 0.00% 0.00%

Profitability

Metric TXMD UPC Drug Manufacturers Specialty & Generic median
Gross margin 100.00% 49.77% 53.94%
Operating margin (120.89%) 0.00% 0.00%
Net margin (6.64%) (6.42%) 0.00%
Free cash flow margin 94.71% 0.00% 0.00%
Return on equity (0.80%) 0.00% (0.40%)
Return on assets (0.57%) 0.00% (3.32%)
Return on invested capital (13.77%) 0.00% 0.00%

Growth

Metric TXMD UPC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 27.78% — 10.01%
EPS growth (last fiscal year) 73.68% 98.71% 49.06%
Revenue growth, 5-year CAGR (45.84%) (10.27%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TXMD UPC Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.17 0.05
Current ratio 3.22 4.05 2.31
Net debt to EBITDA 2.34 10.15 0.97

Dividend

Metric TXMD UPC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric TXMD UPC Drug Manufacturers Specialty & Generic median
Market cap 22.34m 20.85m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack